BLACK DIAMOND THERAPEUTICS I (BDTX)
US09203E1055 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to BDTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.06. This target is 131.49% above the current price.
BDTX was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about BDTX.
In the previous month the buy percentage consensus was at a similar level.
BDTX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-07-14 | Piper Sandler | Initiate | Overweight |
| 2023-06-30 | Stifel | Upgrade | Hold -> Buy |
| 2023-06-28 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-06-27 | Stifel | Reiterate | Hold -> Hold |
| 2023-06-27 | Wedbush | Upgrade | Neutral -> Outperform |
| 2023-05-10 | Wedbush | Reiterate | Neutral |
| 2021-09-30 | Stifel | Initiate | Hold |